Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/TX/Lubbock
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Lubbock, TX

Studies commonly pay $75 to $4,500 per completed study

108 clinical trials are currently recruiting participants within 30 miles of Lubbock. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

108studies recruiting
4+research centers nearby
5condition categories
Live from the NIH registry

Studies recruiting near Lubbock right now

Top 25 of 108 recruiting studies, sorted by proximity — each links to its official registry page

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

Colitis Ulcerative Phase 2 Interventional 204 participants sought
SI Research Associates- Site Number : 8400019 — Lubbock, Texas (2.1 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT06867094)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Annatto-derived GG for Statin-associated Myopathy

Myopathy; Primary Phase 1, Phase 2 Interventional 95 participants sought
Texas Tech University Health Sciences Center — Lubbock, Texas (2.1 mi) · Sponsor: Texas Tech University Health Sciences Center
See eligibility & contact on ClinicalTrials.gov (NCT05312424)

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, KRAS G12C Lung Cancer Phase 3 Interventional 600 participants sought
Texas Tech Health Science Center — Lubbock, Texas (2.1 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06793215)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction

Central Line Associated Blood Stream Infections (CLABSI) N/A Interventional 17,800 participants sought
Covenant Medical Center — Lubbock, Texas (2.1 mi) · Sponsor: Swedish Medical Center
See eligibility & contact on ClinicalTrials.gov (NCT07108660)

A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Crohn Disease Phase 3 Interventional 530 participants sought
Lubbock Gastroenterology — Lubbock, Texas (2.1 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07499232)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Covenant Medical Center-Lakeside — Lubbock, Texas (2.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Breast Cancer N/A Observational 30,000 participants sought
Texas Tech UHSC - Southwest Cancer Center — Lubbock, Texas (2.1 mi) · Sponsor: Agendia
See eligibility & contact on ClinicalTrials.gov (NCT03053193)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT04322318)

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Phase 1, Phase 2 Interventional 960 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: PedAL BCU, LLC
See eligibility & contact on ClinicalTrials.gov (NCT04726241)

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

Stage I Mixed Cell Type Kidney Wilms Tumor, Stage II Mixed Cell Type Kidney Wilms Tumor Phase 3 Interventional 1,656 participants sought
Covenant Children's Hospital — Lubbock, Texas (2.1 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT06401330)

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic Phase 3 Interventional 680 participants sought
Covenant Children's Hospital- Joe Arrington Cancer Research and Treatment Center — Lubbock, Texas (2.1 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07144280)

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Lupus Nephritis Phase 4 Interventional 150 participants sought
Texas Tech University Health Science Center — Lubbock, Texas (2.1 mi) · Sponsor: Aurinia Pharmaceuticals Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07611214)

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma Phase 3 Interventional 720 participants sought
Research Site — Lubbock, Texas (2.1 mi) · Sponsor: Arcus Biosciences, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07011719)

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer Phase 3 Interventional 1,160 participants sought
Research Site — Lubbock, Texas (2.1 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06692738)

Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance Imaging

Stroke, Intracranial Atherosclerotic Stenosis (ICAS) N/A Observational 300 participants sought
Covenant Medical Center — Lubbock, Texas (2.1 mi) · Sponsor: Yale University
See eligibility & contact on ClinicalTrials.gov (NCT05907629)

Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy

Radiation Retinopathy, Visual Impairment Phase 3 Interventional 600 participants sought
Texas Retina Associates — Lubbock, Texas (2.1 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT05844982)
Actively enrolling

Studies you may be able to join near Lubbock

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Lubbock

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Texas Tech Physicians Internal Medicine Clinic

★ 4.9
3601 4th St, Lubbock, TX 79430
(806) 743-3150
"Dr Test is one of the nicest, most personable doctors that i have met in a long time."
— Rena Mashburn, 5★

Department of Internal Medicine Texas Tech University Health Sciences Center

★ 3.7
3601 4th St, Lubbock, TX 79430
(806) 743-3155
"If you don't see the little sign behind a large pillar that denotes where the line starts, and innocently stand in the wrong place, the much older, r…"
— Dan Hammons, 1★

Texas Tech University Health Sciences Center

Lubbock, TX 79415

Texas Tech Physicians: Dermatology

★ 4.9
Texas Tech University, Physicians Medical Pavilion, 3601 4th St 4th Floor, Lubbock, TX 79430
(806) 743-1842
"Dr. Alba Posligua, M.D., in the Texas Tech Physicians Dermatology Clinic provides ***EXCEPTIONAL*** quality care.<br><br>All of the staff were extrem…"
— Kelvin Meeks, 5★

Clinical trials in Lubbock: what's recruiting

The Lubbock area currently has 108 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Lubbock, the most active research areas are:

  • Cancer & Oncology13 studies
  • Immune & Skin4 studies
  • Liver & Kidney3 studies
  • Diabetes & Metabolism1 studies
  • Heart & Vascular1 studies

Every listing shows the study phase, the recruiting site and its distance from Lubbock, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Lubbock

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Lubbock participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

Do I need to be sick to join a clinical trial in Lubbock?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
How do I join a study in Lubbock, TX?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Lubbock?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Lubbock?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Lubbock.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Lubbock typically complete one or two studies per year.

Paid clinical trials near Lubbock

Other metros within reach

Midland, TX16 Amarillo, TX93 Odessa, TX16 Fort Worth, TX606 Denton, TX371 Oklahoma City, OK641 Arlington, TX1,856 Killeen, TX102

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Lubbock Bladder Issues Due To Spinal Cord Injury in Lubbock All conditions

More of TX

Houston3,067 Pasadena3,004 Irving1,967 Grand Prairie1,935 Dallas1,857 Arlington1,856 Garland1,818 Plano1,809 Frisco1,808 Mesquite1,759 San Antonio1,026 Austin723

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts